PortfoliosLab logo

Aptevo Therapeutics Inc. (APVO)

Equity · Currency in USD · Last updated Mar 18, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in Aptevo Therapeutics Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $158 for a total return of roughly -98.42%. All prices are adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%NovemberDecember2023FebruaryMarch
-39.23%
6.47%
APVO (Aptevo Therapeutics Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with APVO

Aptevo Therapeutics Inc.

Return

Aptevo Therapeutics Inc. had a return of -23.71% year-to-date (YTD) and -62.66% in the last 12 months. Over the past 10 years, Aptevo Therapeutics Inc. had an annualized return of -46.42%, while the S&P 500 had an annualized return of 9.33%, indicating that Aptevo Therapeutics Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-13.66%-5.31%
Year-To-Date-23.71%2.01%
6 months-52.67%0.39%
1 year-62.66%-10.12%
5 years (annualized)-46.80%7.32%
10 years (annualized)-46.42%9.33%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-0.86%-7.83%
2022-14.12%-0.66%3.31%-25.64%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aptevo Therapeutics Inc. Sharpe ratio is -0.73. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.90-0.80-0.70-0.60-0.50-0.40-0.30-0.20NovemberDecember2023FebruaryMarch
-0.73
-0.43
APVO (Aptevo Therapeutics Inc.)
Benchmark (^GSPC)

Dividend History


Aptevo Therapeutics Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%NovemberDecember2023FebruaryMarch
-98.42%
-18.34%
APVO (Aptevo Therapeutics Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Aptevo Therapeutics Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aptevo Therapeutics Inc. is 98.42%, recorded on Mar 17, 2023. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.42%Jul 22, 20161675Mar 17, 2023

Volatility Chart

Current Aptevo Therapeutics Inc. volatility is 39.38%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%NovemberDecember2023FebruaryMarch
39.38%
21.17%
APVO (Aptevo Therapeutics Inc.)
Benchmark (^GSPC)